PepGen Inc. Files 8-K with Financial Statements
Ticker: PEPG · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, regulatory-filing
TL;DR
PepGen filed an 8-K with financial docs on Jan 29, 2025. Nothing major else reported.
AI Summary
On January 29, 2025, PepGen Inc. filed an 8-K report. The filing primarily concerns the submission of financial statements and exhibits, with no other specific events or material changes detailed in the provided excerpt. The company is incorporated in Delaware and its principal executive offices are located in Boston, Massachusetts.
Why It Matters
This filing indicates PepGen Inc. is meeting its regulatory reporting requirements by submitting financial statements and exhibits. Investors can review these documents for updates on the company's financial health.
Risk Assessment
Risk Level: low — The filing is a routine regulatory submission of financial statements and exhibits, not indicating any immediate material adverse events.
Key Numbers
- 001-41374 — Commission File Number (Identifies the company's SEC filing history.)
- 85-3819886 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PepGen Inc. (company) — Registrant
- January 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by PepGen Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of January 29, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 29, 2025.
In which state is PepGen Inc. incorporated?
PepGen Inc. is incorporated in Delaware.
What is the address of PepGen Inc.'s principal executive offices?
The address of PepGen Inc.'s principal executive offices is 321 Harrison Avenue, 8th Floor, Boston, Massachusetts, 02118.
Does this filing report any specific 'Other Events' beyond financial statements?
Based on the provided excerpt, the filing is categorized under 'Other Events' and 'Financial Statements and Exhibits', but no specific details of other events are mentioned beyond the submission of financial documents.
Filing Stats: 433 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2025-01-29 16:19:41
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share PEPG Nasdaq Global Select
Filing Documents
- pepg-20250129.htm (8-K) — 41KB
- pepg-ex99_1.htm (EX-99.1) — 25KB
- 0000950170-25-010515.txt ( ) — 185KB
- pepg-20250129.xsd (EX-101.SCH) — 25KB
- pepg-20250129_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On January 29, 2025, PepGen Inc. provided updates on its CONNECT clinical program investigating PGN-EDO51 in Duchenne muscular dystrophy (DMD) for patients amenable to an exon-51 skipping approach. A copy of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this form 8-K and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release issued by PepGen Inc. on January 29, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: January 29, 2025 By: /s/ Noel Donnelly Noel Donnelly, Chief Financial Officer